| Product Code: ETC11643055 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cinv Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cinv Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cinv Market - Industry Life Cycle |
3.4 Israel Cinv Market - Porter's Five Forces |
3.5 Israel Cinv Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Cinv Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 Israel Cinv Market Revenues & Volume Share, By Emetogenic Risk Level, 2021 & 2031F |
3.8 Israel Cinv Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Cinv Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel leading to a higher demand for CINV (Chemotherapy-Induced Nausea and Vomiting) medications. |
4.2.2 Growing awareness among healthcare professionals about the importance of managing CINV effectively to improve patient outcomes. |
4.2.3 Technological advancements in CINV treatment options leading to more effective and targeted therapies. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of new CINV medications in Israel. |
4.3.2 Limited reimbursement policies for CINV drugs affecting patient access and affordability. |
5 Israel Cinv Market Trends |
6 Israel Cinv Market, By Types |
6.1 Israel Cinv Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Cinv Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Israel Cinv Market Revenues & Volume, By 5HT3 Receptor Antagonist, 2021 - 2031F |
6.1.4 Israel Cinv Market Revenues & Volume, By Neurokinin1 (NK1) Receptor Antagonists, 2021 - 2031F |
6.1.5 Israel Cinv Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 Israel Cinv Market Revenues & Volume, By Cannabinoids, 2021 - 2031F |
6.1.7 Israel Cinv Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Israel Cinv Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 Israel Cinv Market Revenues & Volume, By Injectables, 2021 - 2031F |
6.2.3 Israel Cinv Market Revenues & Volume, By Oral Tablets, 2021 - 2031F |
6.2.4 Israel Cinv Market Revenues & Volume, By Transdermal Patches, 2021 - 2031F |
6.3 Israel Cinv Market, By Emetogenic Risk Level |
6.3.1 Overview and Analysis |
6.3.2 Israel Cinv Market Revenues & Volume, By Highly Emetogenic Chemotherapy (HEC), 2021 - 2031F |
6.3.3 Israel Cinv Market Revenues & Volume, By Moderately Emetogenic Chemotherapy (MEC), 2021 - 2031F |
6.3.4 Israel Cinv Market Revenues & Volume, By Low Emetogenic Chemotherapy (LEC), 2021 - 2031F |
6.4 Israel Cinv Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Cinv Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Cinv Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4.4 Israel Cinv Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.5 Israel Cinv Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.6 Israel Cinv Market Revenues & Volume, By Drug Stores, 2021 - 2031F |
7 Israel Cinv Market Import-Export Trade Statistics |
7.1 Israel Cinv Market Export to Major Countries |
7.2 Israel Cinv Market Imports from Major Countries |
8 Israel Cinv Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed CINV medications. |
8.2 Rate of adoption of new CINV treatment guidelines by healthcare providers. |
8.3 Number of clinical trials conducted for innovative CINV therapies in Israel. |
8.4 Patient-reported outcomes related to CINV management and quality of life improvements. |
9 Israel Cinv Market - Opportunity Assessment |
9.1 Israel Cinv Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Cinv Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 Israel Cinv Market Opportunity Assessment, By Emetogenic Risk Level, 2021 & 2031F |
9.4 Israel Cinv Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Cinv Market - Competitive Landscape |
10.1 Israel Cinv Market Revenue Share, By Companies, 2024 |
10.2 Israel Cinv Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here